Evidence map›Paper›PMID 30854233›Full record

ArticleCell death discovery2019

Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells.

Tai-Yu Lai, I-Ju Chen, Ruey-Jen Lin, Guo-Shiou Liao, Hui-Ling Yeo, Ching-Liang Ho, Jen-Chine Wu, Nai-Chuan Chang, Andy Chi-Lung Lee, Alice L Yu

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Impacts of Globo H Ceramide on Tumor Microenvironment.Advances in experimental medicine and biology · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Tai-Yu Lai *Institute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
I-Ju Chen *2Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Ruey-Jen LinInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
Guo-Shiou Liao3Tri-service General Hospital, Department of Surgery, National Defense Medical Center, Taipei, Taiwan.
Hui-Ling YeoInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
Ching-Liang Ho3Tri-service General Hospital, Department of Surgery, National Defense Medical Center, Taipei, Taiwan.
Jen-Chine WuInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
Nai-Chuan ChangInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
Andy Chi-Lung LeeInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.
Alice L YuInstitute of Stem cell and Translational Cancer Research, Chang Gung Memorial Hospital, Linkou, Taiwan.ORCID 0000-0003-2444-0505
Chang Gung Memorial Hospital · TWNational Defense Medical Center · TWGenomics Research Center, Academia Sinica · TWUniversity of San Diego · US

Funding

NTP INFORMATION SYSTEMS SUPPORT27305C0011 · NIEHS · Z-TECH CORPORATION · 2007 to 2009
$4.3M
PROVIDE RABBITS, RATS MICE, HAMSTERS GERBILS, GUINEA PIGS27307C0012 · NIEHS · PI BOLEN, WAYNE · 2007 to 2007
$1.0M
PROVIDE RABBITS, RATS, MICE, HAMSTERS, GERBILS, GUINEA PIGS27307C0011 · NIEHS · PI BOLEN, WAYNE · 2007 to 2007
$500k
NIEHS NIH HHS 27305C0011NIEHS NIH HHS 27307C0011NIEHS NIH HHS 27307C0012NIEHS NIH HHS 27398C0011
6 · The paper itself

Abstract

FUT1 and FUT2 encode alpha 1, 2-fucosyltransferases which catalyze the addition of alpha 1, 2-linked fucose to glycans. Glycan products of FUT1 and FUT2, such as Globo H and Lewis Y, are highly expressed on malignant tissues, including breast cancer. Herein, we investigated the roles of FUT1 and FUT2 in breast cancer. Silencing of FUT1 or FUT2 by shRNAs inhibited cell proliferation in vitro and tumorigenicity in mice. This was associated with diminished properties of cancer stem cell (CSC), including mammosphere formation and CSC marker both in vitro and in xenografts. Silencing of FUT2, but not FUT1, significantly changed the cuboidal morphology to dense clusters of small and round cells with reduced adhesion to polystyrene and extracellular matrix, including laminin, fibronectin and collagen. Silencing of FUT1 or FUT2 suppressed cell migration in wound healing assay, whereas FUT1 and FUT2 overexpression increased cell migration and invasion in vitro and metastasis of breast cancer in vivo. A decrease in mesenchymal like markers such as fibronectin, vimentin, and twist, along with increased epithelial like marker, E-cadherin, was observed upon FUT1/2 knockdown, while the opposite was noted by overexpression of FUT1 or FUT2. As expected, FUT1 or FUT2 knockdown reduced Globo H, whereas FUT1 or FUT2 overexpression showed contrary effects. Exogenous addition of Globo H-ceramide reversed the suppression of cell migration by FUT1 knockdown but not the inhibition of cell adhesion by FUT2 silencing, suggesting that at least part of the effects of FUT1/2 knockdown were mediated by Globo H. Our results imply that FUT1 and FUT2 play important roles in regulating growth, adhesion, migration and CSC properties of breast cancer, and may serve as therapeutic targets for breast cancer.

Identifiers

PMID30854233
PMCPMC6403244
OpenAlexW2919977068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.